This comprehensive guide examines DTS (Diabetes Technology Society) Error Grid Analysis as the modern, consensus-driven standard for evaluating the clinical accuracy of Continuous Glucose Monitoring (CGM) systems.
This comprehensive review addresses the critical gap in standardized continuous glucose monitoring (CGM) calibration protocols for multiple daily injection (MDI) insulin users, a population distinct from pump users.
Continuous Glucose Monitoring (CGM) is a transformative technology in diabetes management, yet its accuracy can vary significantly between Type 1 (T1D) and Type 2 (T2D) populations.
This article provides a comprehensive analysis for researchers and drug development professionals on the critical challenge of Continuous Glucose Monitor (CGM) accuracy during the post-exercise recovery phase.
This article provides a comprehensive analysis of Continuous Glucose Monitor (CGM) performance during periods of rapid glucose change (RGC), a critical challenge in metabolic research and drug development.
This article provides a detailed examination of the well-documented reduction in Continuous Glucose Monitor (CGM) accuracy during the initial 12-hour wear period compared to subsequent days.
This article provides a comprehensive review of Continuous Glucose Monitor (CGM) performance across the full physiological glucose spectrum, moving beyond aggregated metrics like MARD.
This comprehensive review examines the performance metrics, specifically the Mean Absolute Relative Difference (MARD), of Continuous Glucose Monitoring (CGM) systems across heterogeneous patient groups, including pediatric, geriatric, pregnant, and critically...
This article provides a detailed examination of the bioequivalence between biosimilar insulin lispro and its reference product (Humalog®).
This article provides a comprehensive, evidence-based review of human clinical trials investigating the differential impacts of Bifidobacterium and Lactobacillus probiotic strains on glucose metabolism.